🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

Recruitingn/aAges 18 Years - 65 YearsAllSecond Affiliated Hospital, Zhejiang University, …
NCT06543602 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave. The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system for agitated critically ill patients Participants already taking multi-modal evaluation monitoring system as part of their regular medical care for agitated critically ill patients will compare their effectiveness for agitation for 3 years.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients at risk of agitation in the ICU * Patients with RASS score -2 and above * ≦ 65 years old, ≧ 18 years old Exclusion Criteria: * The affected party refused to participate in this study * Missing/incomplete information * Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives * Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression * Patients with limb impairment and amputation * Spinal cord injury, limb movement/sensory limitations * Patients with pre-existing neurological/psychiatric diseases * Patients with malignant tumors * Patients with infectious diseases * Patients with terminal disease and dying disease * Abnormal behavior due to head injury or craniocerebral disease
💊

What it tests

  • multi-model monitoring and alert
📍

Where

2 sites
the second affiliated hospital, Zhejiang University school of medicine
Hangzhou, China
SAHZU
Hanzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy